Raphael Townshend, Atomic AI founder and CEO
Former DeepMind intern launches Atomic AI to 'parse' RNA structure for new small molecules
Another artificial intelligence startup has entered the drug discovery field, this time on a mission to fuel new RNA small molecules.
Atomic AI revealed a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.